Insulet Corp. (PODD)
$138.13-1.20%Close
SELLRECOVERY · day 7
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $9.6B
- Beta
- 1.10
- P/E (TTM)
- 25.77
- Short % float
- 7.77%
- Days to cover
- 3.9
- SI change
- +5.4%
- 1W
- +2.52%
- 1M
- +0.24%
- vs SPY 1W
- +2.66%
- vs SPY 1M
- -2.27%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 62
- VALUE
- 30
- GROWTH
- 67
- GARP
- 75
- TYPE
- Growth Compounder (blended)
Composite of Value · Growth · GARP
ROIC16.0%
REV YoY-
ROE26.7%
EPS YoY-
ROA11.9%
GROSS71
OP17
NET12
[VALUATION]
P/E TTM25.77
P/E FWD20.31
SECTOR PE20.34
INDUSTRY PE22.66
P/B6.73
P/FCF-
EV/EBITDA15.18
EV/EBIT-
PEG1.20
FCF YIELD-
RISK
INT COV-
D/E66.69
ALTMAN Z-
CURR RATIO2.48
ND/EBITDA-
BETA1.10
Company news
FAQ
- What is LOPJLB’s current signal on PODD?
- LOPJLB’s latest quantitative signal on Insulet Corp. (PODD) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is PODD in?
- Insulet Corp. (PODD) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Insulet Corp. (PODD) do?
- Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obta…